A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
Hoffmann-La Roche
Hoffmann-La Roche
St. Jude Children's Research Hospital
Hoffmann-La Roche
Sanford Health
Universidad Nacional Autonoma de Mexico
National Cancer Institute (NCI)
Boston Pharmaceuticals
University of Milano Bicocca
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline